American Portfolios Advisors’s Transmedics TMDX Stock Holding History

American Portfolios Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$119K	Sell	2,845 -4,419	-61%	-$192K	0.01%	1258
2022 Q2	$228K	Sell	7,264 -1,657	-19%	-$44.2K	0.01%	986
2022 Q1	$240K	Sell	8,921 -3,159	-26%	-$56.6K	0.01%	1074
2021 Q4	$231K	Buy	12,080 +8,175	+209%	+$205K	0.01%	1081
2021 Q3	$129K	Buy	3,905 +3,051	+357%	+$93.2K	﹤0.01%	1335
2021 Q2	$28.3K	Sell	854 -818	-49%	-$22.7K	﹤0.01%	2035
2021 Q1	$69.4K	Buy	1,672 +1,221	+271%	+$37.6K	﹤0.01%	1465
2020 Q4	$8.97K	Sell	451 -9	-2%	-$133	﹤0.01%	2155
2020 Q3	$6.34K	Buy	460 +277	+151%	+$4.75K	﹤0.01%	2171
2020 Q2	$3.28K	Sell	183 -90	-33%	-$1.41K	﹤0.01%	2376
2020 Q1	$3.3K	Buy	+273	New	+$4.57K	﹤0.01%	2238

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCP

Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

American Portfolios Advisors's TMDX Position: Q3 2022 in Review

American Portfolios Advisors reduced its Transmedics (TMDX) stake by 61% in Q3 2022, selling an estimated $192K and leaving 2,845 shares worth $119K. The position accounts for 0.01% of the portfolio, ranked #1258.

American Portfolios Advisors first reported a position in TMDX in Q1 2020 and has held it in 11 quarters since. The position peaked at $240K in Q1 2022. 179 funds tracked by Wall St. Rank hold TMDX as of Q3 2022.

American Portfolios Advisors held 2,845 shares of Transmedics worth $119K as of Q3 2022.
American Portfolios Advisors sold 4,419 Transmedics shares in Q3 2022, an estimated $192K.
Transmedics made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1258 holding.
American Portfolios Advisors first reported a position in Transmedics in Q1 2020 and has held it in 11 quarters since.
American Portfolios Advisors's Transmedics position peaked at $240K in Q1 2022.
179 funds tracked by Wall St. Rank held Transmedics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.